Publicacions en què col·labora amb Daniel Padro Hernández (19)

2024

  1. Multimodal imaging of the role of hyperglycemia following experimental subarachnoid hemorrhage

    Journal of Cerebral Blood Flow and Metabolism, Vol. 44, Núm. 5, pp. 726-741

2021

  1. Comparison of analytical methods for antibody conjugates with application in nuclear imaging – Report from the trenches

    Nuclear Medicine and Biology, Vol. 102-103, pp. 24-33

2020

  1. In vivo PET Imaging of Gliogenesis After Cerebral Ischemia in Rats

    Frontiers in Neuroscience, Vol. 14

  2. In vivo multimodal imaging of adenosine A1 receptors in neuroinflammation after experimental stroke

    Theranostics, Vol. 11, Núm. 1, pp. 410-425

2019

  1. Functionalizing NaGdF4:Yb, Er upconverting nanoparticles with bone-targeting phosphonate ligands: Imaging and in vivo biodistribution

    Inorganics, Vol. 7, Núm. 5

2018

  1. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1335-1344

  2. Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles

    Biomaterials, Vol. 170, pp. 95-115

  3. In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia

    GLIA, Vol. 66, Núm. 8, pp. 1611-1624

  4. PET Imaging of Crossed Cerebellar Diaschisis after Long-Term Cerebral Ischemia in Rats

    Contrast Media and Molecular Imaging, Vol. 2018

2017

  1. Evaluation of the novel TSPO radiotracer [18F] VUIIS1008 in a preclinical model of cerebral ischemia in rats

    EJNMMI Research, Vol. 7

  2. PET imaging of cannabinoid type 2 receptors with [ 11 C]A-836339 did not evidence changes following neuroinflammation in rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 37, Núm. 3, pp. 1163-1178

2016

  1. In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, Núm. 6, pp. 1124-1138

  2. PET imaging with [18F]FSPG evidences the role of system xc- on brain inflammation following cerebral ischemia in rats

    Theranostics, Vol. 6, Núm. 11, pp. 1753-1767

2015

  1. In vivo PET imaging of the α4β2 nicotinic acetylcholine receptor as a marker for brain inflammation after cerebral ischemia

    Journal of Neuroscience, Vol. 35, Núm. 15, pp. 5998-6009

2013

  1. In vivo imaging of dopaminergic neurotransmission after transient focal ischemia in rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 33, Núm. 2, pp. 244-252

  2. PET imaging of serotoninergic neurotransmission with [11C]DASB and [18F]altanserin after focal cerebral ischemia in rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 33, Núm. 12, pp. 1967-1975

  3. [18F]Fluorination of o-carborane via nucleophilic substitution: Towards a versatile platform for the preparation of 18F-labelled BNCT drug candidates

    Chemical Communications, Vol. 49, Núm. 98, pp. 11491-11493

2012

  1. Biodistribution and metabolism of 11C-labeled Kendine 91 in mice and rats

    Applied Radiation and Isotopes, Vol. 70, Núm. 10, pp. 2545-2551

2011

  1. Synthesis of D2 receptor ligand analogs incorporating one dicarba-closo-dodecaborane unit

    Tetrahedron Letters, Vol. 52, Núm. 5, pp. 615-618